Chronic Kidney Disease, Hyperkalemia and Echocardiographic Changes

Launched by SAGLIK BILIMLERI UNIVERSITESI · Oct 8, 2024

Keywords

ClinConnect Summary

This clinical trial is studying patients with chronic kidney disease (CKD) who have high potassium levels, a condition known as hyperkalemia. The researchers want to understand how these high potassium levels affect the heart by comparing heart images (echocardiograms) and electrical activity readings (ECGs) before and after treatment. Importantly, the doctors treating the patients will not change their treatment plans because of the study, ensuring that patients receive the necessary care promptly.

To participate in this study, individuals must be over 18 years old, have CKD with a specific kidney function level (eGFR below 60), and have high potassium levels found in the emergency department. Participants will have their heart function assessed through echocardiograms and ECGs, and they will be asked to sign a consent form to join the study. Overall, this trial aims to gain valuable insights into how high potassium impacts heart health in patients with CKD.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Patients over 18 years old
• • 2. Chronic kidney disease patients with eGFR \< 60 mL/min/1.73 m²
• • 3. Patients with hyperkalemia detected in the emergency department
• • 4. Patients willing to participate in the study and who sign the consent form
• Exclusion Criteria:
• • 1. Patients under 18 years old
• • 2. Patients who do not wish to participate in the study
• • 3. Patients without chronic kidney damage
• • 4. Patients without detected hyperkalemia
• • 5. Patients needing cardiopulmonary resuscitation due to hyperkalemia